Kewaunee Scientific (KEQU) Cash from Financing Activities (2010 - 2026)

Kewaunee Scientific's Cash from Financing Activities history runs 17 years deep, the most recent figure standing at -$2.9 million for Q2 2026.

• On a quarterly basis, Cash from Financing Activities rose 32.0% year-over-year to -$2.9 million in Q2 2026; TTM through Apr 2026 was -$19.3 million, a 360.77% decrease from a year earlier, with the FY2026 full-year figure at -$19.3 million, down 360.77% from the prior year.
• Cash from Financing Activities grew to -$2.9 million in Q2 2026 per KEQU's latest filing, from -$14.1 million in the prior quarter.
• Across five years, Cash from Financing Activities topped out at $14.6 million in Q1 2025 and bottomed at -$14.1 million in Q1 2026.
• The 5-year median for Cash from Financing Activities is -$1.2 million (2025), against an average of $232000.0.
• Across the five-year window, Cash from Financing Activities surged 639.31% in 2023 and plunged 526.53% in 2025, its largest moves.
• Year by year, Cash from Financing Activities stood at -$145000.0 in 2022, then jumped by 639.31% to $782000.0 in 2023, then tumbled by 512.92% to -$3.2 million in 2024, then surged by 73.58% to -$853000.0 in 2025, then sank by 245.84% to -$2.9 million in 2026.
• Per Business Quant, the three latest KEQU Cash from Financing Activities figures stand at -$2.9 million (Q2 2026), -$14.1 million (Q1 2026), and -$853000.0 (Q4 2025).